当前位置: X-MOL 学术Leukemia › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Prognostic value of antigen expression in multiple myeloma: A PETHEMA/GEM study on 1,265 patients enrolled in four consecutive clinical trials
Leukemia ( IF 11.4 ) Pub Date : 2017-11-03 , DOI: 10.1038/leu.2017.320
P Arana , , B Paiva , M-T Cedena , N Puig , L Cordon , M-B Vidriales , N C Gutierrez , F Chiodi , L Burgos , L-L Anglada , J Martinez-Lopez , M-T Hernandez , A-I Teruel , M Gironella , M-A Echeveste , L Rosiñol , R Martinez , A Oriol , J De la Rubia , A Orfao , J Blade , J-J Lahuerta , M-V Mateos , J-F San Miguel

Prognostic value of antigen expression in multiple myeloma: A PETHEMA/GEM study on 1,265 patients enrolled in four consecutive clinical trials

Prognostic value of antigen expression in multiple myeloma: A PETHEMA/GEM study on 1,265 patients enrolled in four consecutive clinical trials, Published online: 03 November 2017; doi:10.1038/leu.2017.320



中文翻译:

抗原表达在多发性骨髓瘤中的预后价值:一项PETHEMA / GEM研究对1,265名患者进行了四次连续临床试验

抗原表达在多发性骨髓瘤中的预后价值:一项PETHEMA / GEM研究对1,265名患者进行了四次连续临床试验

抗原表达在多发性骨髓瘤中的预后价值:一项PETHEMA / GEM研究对1,265名患者进行了四项连续临床试验,在线发表于:2017年11月3日;doi:10.1038 / leu.2017.320

更新日期:2017-11-03
down
wechat
bug